Natural product-derived PD-L1 pathway blockade enhances the efficacy of Cancer immunotherapy: Marrubium vulgare extract inhibits the expression of PD-L1, inhibits inflammatory signalling and the number of tumor-infiltrating lymphocytes and macrophages, increases Cytotoxic activity of T-cells, decreases tumor burden and increases survival via up-regulation of its target gene, 21/April/2017, 10.15 pm

Antiviral therapy for HIV virus: 15-Deoxy-Δ12,14 Prostaglandin J2 (15d-PGJ2) increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production via up regulation of its target gene, 21/April/2017, 4.03 pm
April 21, 2017
Swimming therapy for Myocardial Infarction: Swimming therapy inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction via up regulation of PNUTS, 21/April/2017, 10.45 am
April 21, 2017
Show all

Introduction:What they say:

A recent study from Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Unit 108, 1515 Holcombe Boulevard, Houston, TX 77030, USA shows that “Deubiquitination and Stabilization of PD-L1 by CSN5.” This study was published in the 12 December 2016 issue of Cancer cell (one of the best journals in Cancer Science with an impact factor of 23.523) by Prof Mien-Chie Hung, Lim SO and others.


What we say

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-derived PD-L1 pathway blockade enhances the efficacy of Cancer immunotherapy: Marrubium vulgare extract inhibits the expression of PD-L1, inhibits inflammatory signalling and the number of tumor-infiltrating lymphocytes and macrophages, increases Cytotoxic activity of T-cells, decreases tumor burden and increases survival via up-regulation of its target gene


What is known?

It has recently been shown that blocking cell surface receptor PD-1 with antibodies one could make tumors shrink. This work, relating to Cancer immunotherapy, has been chosen as Science’s breakthrough of the year recently.


From Research Findings to Therapeutic opportunity

Marrubium vulgare extract, by increasing the expression of its target gene, it may  diminish the expression of PD-L1 (fig. 1). Thereby, it may: (i) inhibit inflammatory TNFα signaling; (ii) decrease the number of tumor-infiltrating lymphocytes and macrophages; (iii) increase T-cell anti-tumor immunity; (iv) decrease tumor burden; and (v) increase survival of patients with breast cancer (fig. 1).  

Marrubium vulgare extract inhibits PDL1 expression and promotes tumor regression

Figure 1. Mechanistic insight into how Marrubium vulgare extract enhances the efficacy of cancer immunotherapy. Marrubium vulgare extract, by decreasing the expression of PD-L1 in cancer cells, it augments T-cell mediated anti-tumor immunity

Thus, pharmacological formulations encompassing “Marrubium vulgare extract or an active compound isolated from it either alone or in combination with other drugs may be used to (i) inhibit the progression of tumors; and (ii) enhance the efficacy of Cancer immunotherapy.price-50

[easy_payment currency=”USD”]


Details of the research findings:

Idea Proposed/Formulated (with experimental evidence) by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Amount: $50#

Undisclosed mechanistic information: How Marrubium vulgare extract inhibits the expression of PD-L1 and augments anti-tumor immunity

For purchase and payment details, you may reach us at admin@genomediscovery.org

# Research cooperation


References

Citation: Boominathan, L., Natural product-derived PD-L1 pathway blockade enhances the efficacy of Cancer immunotherapy: Marrubium vulgare extract inhibits the expression of PD-L1, inhibits inflammatory signalling and the number of tumor-infiltrating lymphocytes and macrophages, increases Cytotoxic activity of T-cells, decreases tumor burden and increases survival via up-regulation of its target gene, 21/April/2017, 10.15 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or http://newbioideas.com/

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.